Leonidas Benetatos, Elisavet Apostolidou, Vasileios Georgoulis, Georgios S. Markopoulos, Savvas Dimitriadis, Eleftheria Hatzimichael et al. Adjusted Indirect Comparison Between Epcoritamab‐R2 and Tafasitamab‐R2 in Relapse/Refractory Follicular Lymphoma. // Hematological Oncology. – 2026. – DOI: 10.1002/hon.70282. – URL: https://onlinelibrary.wiley.com/doi/10.1002/hon.70282?af=R
Leonidas Benetatos, Elisavet Apostolidou, Vasileios Georgoulis, Georgios S. Markopoulos, Savvas Dimitriadis, Eleftheria Hatzimichael, & Eleni Kapsali (2026). Adjusted Indirect Comparison Between Epcoritamab‐R2 and Tafasitamab‐R2 in Relapse/Refractory Follicular Lymphoma. Hematological Oncology. https://doi.org/10.1002/hon.70282
Leonidas Benetatos, et al. “Adjusted Indirect Comparison Between Epcoritamab‐R2 and Tafasitamab‐R2 in Relapse/Refractory Follicular Lymphoma.” Hematological Oncology, 2026. doi:10.1002/hon.70282.
@article{Benetatos2026,
title = {Adjusted Indirect Comparison Between Epcoritamab‐R2 and Tafasitamab‐R2 in Relapse/Refractory Follicular Lymphoma},
author = {Benetatos, Leonidas and Apostolidou, Elisavet and Georgoulis, Vasileios and Markopoulos, Georgios S. and Dimitriadis, Savvas and Hatzimichael, Eleftheria and Kapsali, Eleni},
journal = {Hematological Oncology},
year = {2026},
doi = {10.1002/hon.70282},
url = {https://onlinelibrary.wiley.com/doi/10.1002/hon.70282?af=R}
}